The federal government’s 340B Drug Pricing Program is designed to deliver significant drug price savings to eligible health care organizations and their patients. 

HASC Endorsed Business Partner SunRx recently presented a webinar, A Post-Election Regulatory Update on 340B. The session is still available to view on-demand.

The webinar features expert Jeff Davis of the legal firm Baker Donelson, who covers the latest in 340B regulatory and legislative developments and shares insights on how you can best position your 340B program for success in 2021 and beyond.

Providers will benefit from the overview of 340B including past, present, and future in this webcast that covers:

• How we got here and what you need to know about the lawsuit over drug companies refusing 340B discounts.
• How the recent manufacturer actions may impact your 340B program.
• What you need to know about new guidance from HHS.
• Actions to consider now to position your program for the future.

Register now for the on-demand webinar: https://webinars.on24.com/sunrx/webinarseries1

SUNRx is a HASC Endorsed Business Partner and helps manage discount drug programs, save money, expand access and generate the resources necessary to serve the nation’s uninsured.

With any questions, or for more information on the association’s Endorsed Business Partner program, please contact HASC Director, Member Relations and Association Services Darryl Sanford.

Contact:
Darryl Sanford
(213) 538-0772
dsanford@hasc.org